These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2351565)

  • 21. Melanoma antigen expression and metastatic ability of mutant B16 melanoma clones.
    Nozue M; Sakiyama H; Tsuchiya K; Hirabayashi Y; Taniguchi M
    Int J Cancer; 1988 Nov; 42(5):734-8. PubMed ID: 3053466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
    Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
    J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.
    Anichini A; Fossati G; Parmiani G
    Int J Cancer; 1985 May; 35(5):683-9. PubMed ID: 3158614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon gamma.
    Anichini A; Mortarini R; Fossati G; Parmiani G
    Int J Cancer; 1986 Oct; 38(4):505-11. PubMed ID: 3093392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of stable cytolytic T-cell clones directed against autologous human melanoma.
    Hérin M; Lemoine C; Weynants P; Vessière F; Van Pel A; Knuth A; Devos R; Boon T
    Int J Cancer; 1987 Mar; 39(3):390-6. PubMed ID: 3493226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.
    Knuth A; Wölfel T; Klehmann E; Boon T; Meyer zum Büschenfelde KH
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2804-8. PubMed ID: 2784858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins.
    Mortarini R; Anichini A; Parmiani G
    Int J Cancer; 1991 Feb; 47(4):551-9. PubMed ID: 1995484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysis of cultured human melanoma M10 cells by polyclonal xenoantibodies to melanoma-associated antigens.
    Curry RA; Quaranta V; Pellegrino MA; Ferrone S
    Cancer Res; 1981 Feb; 41(2):463-6. PubMed ID: 7448792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma.
    Gandoglia I; Ivaldi F; Carrega P; Armentani E; Ferlazzo G; Mancardi G; Kerlero de Rosbo N; Uccelli A; Laroni A
    Immunol Lett; 2017 Jan; 181():109-115. PubMed ID: 27919749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells.
    Houghton AN; Real FX; Davis LJ; Cordon-Cardo C; Old LJ
    J Exp Med; 1987 Mar; 165(3):812-29. PubMed ID: 3102678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma and immunity.
    Rheins LA; Nordlund JJ
    Immunol Ser; 1989; 46():769-87. PubMed ID: 2484957
    [No Abstract]   [Full Text] [Related]  

  • 33. Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones.
    Degiovanni G; Lahaye T; Hérin M; Hainaut P; Boon T
    Eur J Immunol; 1988 May; 18(5):671-6. PubMed ID: 2967757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological and enzymatic features of human melanoma clones with different invasive potential.
    Supino R; Mapelli E; Sanfilippo O; Silvestro L
    Melanoma Res; 1992 Dec; 2(5-6):377-84. PubMed ID: 1363380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
    Sigalotti L; Fratta E; Coral S; Tanzarella S; Danielli R; Colizzi F; Fonsatti E; Traversari C; Altomonte M; Maio M
    Cancer Res; 2004 Dec; 64(24):9167-71. PubMed ID: 15604288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
    Anichini A; Maccalli C; Mortarini R; Salvi S; Mazzocchi A; Squarcina P; Herlyn M; Parmiani G
    J Exp Med; 1993 Apr; 177(4):989-98. PubMed ID: 8459226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens.
    Kubo H; Abe J; Obata F; Nakajima H; Tsunoda M; Ogawa A; Nakayama S; Beck Y; Kohsaka T; Darrow TL; Abdel-Wahab Z; Saida T; Takiguchi M
    Cancer Res; 1996 May; 56(10):2368-74. PubMed ID: 8625313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential lysis of melanoma clones by autologous recombinant interleukin 2-activated lymphocytes. Relationship with spontaneous resistance to doxorubicin (Dx).
    Gambacorti-Passerini C; Rivoltini L; Supino R; Mariani M; Parmiani G
    Int J Cancer; 1988 Oct; 42(4):544-8. PubMed ID: 3262590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines.
    Dufour E; Carcelain G; Gaudin C; Flament C; Avril MF; Faure F
    J Immunol; 1997 Apr; 158(8):3787-95. PubMed ID: 9103444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.